Archived from the original on 25 April 2012
The active ingredient works by inhibiting the H+/K+-ATPase system, therefore blocking acid from being secreted into the stomach
Originally characterized at the University of Florida by the Stephen ORahilly and Robert Kraft groups, the compound has been studied in preclinical research for body composition, adipose tissue lipolysis, glucose homeostasis, skeletal muscle aging, and metabolic disease endpoints
or low potassium level - leg cramps, constipation, irregular heartbeats, fluttering in your chest, increased thirst or urination, numbness or tingling, muscle weakness or limp feeling
Resting metabolic rate typically decreases during weight loss as your body adapts to lower energy intake and reduced body mass